Related Experiment Videos
Sudden infant death and liver phosphoenolpyruvate carboxykinase analysis
Insights
This study investigated the impaired gluconeogenesis-terminal hypoglycemia hypothesis in sudden infant death syndrome (SIDS). Lower hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity was found in SIDS infants, but terminal hypoglycemia was not confirmed, failing to support the hypothesis.
Area of Science:
- Biochemistry
- Pediatrics
- Pathology
Background:
- Sudden Infant Death Syndrome (SIDS) remains a significant concern in infant mortality.
- The impaired gluconeogenesis-terminal hypoglycemia hypothesis proposes a potential mechanism for SIDS.
- Understanding metabolic factors in SIDS is crucial for identifying risk factors and prevention strategies.
Purpose of the Study:
- To investigate the impaired gluconeogenesis-terminal hypoglycemia hypothesis in SIDS.
- To assess key metabolic indicators, including hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity, in SIDS victims.
Main Methods:
- Postmortem analysis of 52 infants (3 weeks to 7 months old).
- Measurement of stomach contents, vitreous humor glucose, hepatic glycogen, and hepatic PEPCK activity.
- Comparison of these parameters between SIDS and non-SIDS groups.
Main Results:
- No significant differences in stomach contents, vitreous humor glucose, or liver glycogen between SIDS and non-SIDS infants.
- Significantly lower hepatic PEPCK activity observed in SIDS victims compared to non-SIDS controls.
- Despite lower PEPCK activity, terminal hypoglycemia was not demonstrated in SIDS infants.
Conclusions:
- The study did not substantiate the impaired gluconeogenesis-terminal hypoglycemia hypothesis for SIDS.
- Lower PEPCK activity in SIDS infants suggests potential alterations in gluconeogenic capacity.
- Further research is needed to fully elucidate the metabolic underpinnings of SIDS.
Abstract:
In an effort to substantiate the impaired gluconeogenesis-terminal hypoglycemia hypothesis of sudden infant death syndrome (SIDS), 52 infants ranging from 3 weeks to 7 months of age which had been brought to autopsy were studied. The stomach contents, vitreous humor glucose concentrations, hepatic glycogen content and hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity were measured as part of the laboratory component of the postmortem investigation. The stomach contents, vitreous humor glucose concentrations and liver glycogen content were similar in SIDS/and non-SIDS victims. PEPCK activity was, however, significantly lower in SIDS (p < 0.001) victims and in SIDS with other findings (p < 0.01) victims when compared to non-SIDS victims. Despite the fact that SIDS victims had lower hepatic PEPCK activity and hence potentially lower gluconeogenic capacity, terminal hypoglycemia could not be demonstrated in this group as compared to the SIDS with other findings and the non-SIDS infants. The impaired gluconeogenesis-terminal hypoglycemia hypothesis thus could not be substantiated.